A dermatologist can distinguish between the two types through examination and, if needed, scalp biopsy
We're here to help
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
The Cranbury, New Jerseybased biotech announced FDA acceptance of its Biologics License Application for RP-L201 (marnetegragene autotemcel), an investigational lentiviral vector (LV)-based gene therapy for LAD-I, a rare, genetic immune disorder that predisposes patients to frequent and often fatal infections
Anyone hoping for a permanent change
Seek clinical practice advice for any laboratory work involving injections